Skip to main content
. 2019 Apr 14;52(4):e12614. doi: 10.1111/cpr.12614

Figure 2.

Figure 2

SicircDOCK1 inhibited the progression of BC cells in vitro. (A and B) qPCR analysis of the knockdown efficiency of siRNAs against circDOCK1 in the 5637 and EJ‐M3 cell lines. GAPDH was used as the control. (C and D) CCK8 assay for the viability of 5637 and EJ‐M3 cells transfected with the sicircDOCK1 and control siRNAs (siNC). (E and F) EdU assay for the proliferation of 5637 and EJ‐M3 cells transfected with the sicircDOCK1 and control siRNAs (siNC). (G) Transwell assay for the migration potential of 5637 and EJ‐M3 cells transfected with the sicircDOCK1 and control siRNAs (siNC). Each experiment was repeated a minimum of three times. The symbol * denotes a significant difference (P < 0.05), while ** represents a highly significant difference (P < 0.01) in a two‐tailed Student's t test